#VisualAbstract: Percutaneous Coronary Intervention in severe ischemic left ventricular dysfunction does not improve outcomes compared to optimal medical therapy alone
Click here to read this study in NEJM.
Read More
studygraphics
#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms
Click here to read this study in JAMA Psychiatry.
Read More
#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
Click to read this study in JAMA Otolaryngology – Head & Neck Surgery.
Read More
#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
1. Pembrolizumab-alone or pembrolizumab-chemotherapy prolonged overall survival vs...
Read More
#VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma
1. 4-year recurrence-free survival was significantly higher with nivolumab plus ipilimumab...
Read More
#VisualAbstract: Neoadjuvant atezolizumab is not effective for node-positive HER2⁺ breast cancer
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Cefepime/enmetazobactam superior to piperacillin/tazobactam for the treatment of complicated urinary tract infections and acute pyelonephritis
1. In this randomized controlled trial, treatment of acute pyelonephritis and complicated urinary...
Read More
#VisualAbstract: Asundexian does not reduce the risk of recurrent strokes after non-cardioembolic ischemic stroke
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable...
Read More
#VisualAbstract: Dapagliflozin slows disease progression in patients with heart failure with preserved ejection fraction
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in...
Read More
#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Effectiveness of stand-alone telephone-delivered intervention for reducing problem alcohol use
1. In this randomized controlled trial, in participants with problem alcohol use, individuals in...
Read More
#VisualAbstract: Minocycline is not effective at reducing depressive symptoms in treatment-refractory depression
Click here to read this study in JAMA.
Read More
#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma
Click to read this study in Clinical Cancer Research.
Read More
#VisualAbstract: Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients
1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in...
Read More
#VisualAbstract: Polypill reduces adverse cardiovascular events among older patients with recent myocardial infarction
Click here to read this study in NEJM.
Read More
#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma
Click to read this study in the Journal of Clinical Oncology.
Read More
#VisualAbstract: Screening patients with atrial fibrillation with an implantable loop recorder does not decrease the incidence of subsequent stroke
1. Amongst patients aged 70 or older, screening for atrial fibrillation with an implantable loop...
Read More
#VisualAbstract: Functional testing nonsuperior to routine care for percutaneous coronary intervention patients
1. In high-risk patients who had undergone percutaneous coronary intervention (PCI), routine...
Read More